Moira Aitken
Pulmonary Disease
Credentials: · · ·
History
- 1981–1983
Pulmonary Disease
- 1978–1981
Royal Infirmary and Western General Hospital in Edinburgh
Research
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation
New England Journal of Medicine · 2010 · 629 citations
Thorax · 2012 · 420 citations
Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study
The Lancet · 2003 · Last of 4 authors · 310 citations
47 papers · 2 as a fellow
17 papers
16 papers · 8 as a fellow
- RG
14 papers
12 papers · 1 as a fellow
11 papers
11 papers
10 papers
Grants
- 1997–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $198.4K · University of Washington
- 1996–2001
Development Toward an in vivo Model for Cf Gene Therapy
National Heart, Lung, and Blood Institute · R29
Contact PI · $406.4K · University of Washington
- 1997–1999
Molecular Therapy Core Centers
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $218.8K · University of Washington
- 1987–1992
Cellular Differentiation of Airway Epithelium
National Heart, Lung, and Blood Institute · K08
Contact PI · $323.7K · University of Washington
Clinical trials
- 2014–2017
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Principal investigator · Completed · Phase 3
Syntara
- 2008–2010
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
Principal investigator · Completed · Phase 3
Syntara